ReP USP - Resultado da busca

Artigo de periodico
Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors (2021)
Freire, Marjorie Caroline Liberato Cavalcanti ; Noske, Gabriela Dias; Bitencourt, Natália V.; Sanches, Paulo R. S.; Santos-Filho, Norival A.; Oliveira, Victor Gawriljuk Ferraro; Souza, Eduardo Pereira de ; Nogueira, Victor Henrique Rabesquine ; Godoy, Mariana Ortiz de; Nakamura, Aline Minali; Fernandes, Rafaela Sachetto ; Godoy, Andre Schutzer de ; Juliano, Maria A.; Peres, Bianca de Miranda ; Barbosa, Cecília G.; Moraes, Carolina B.; Freitas Junior, Lucio Holanda Gondim de ; Cilli, Eduardo Maffud ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius
Source: Molecules. Unidades: IFSC, ICB
Subjects: COVID-19, CORONAVIRUS, PLANEJAMENTO DE FÁRMACOS, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREIRE, Marjorie Caroline Liberato Cavalcanti et al. Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors. Molecules, v. 26, n. 16, p. 4896-1-4896-17, 2021Tradução . . Disponível em: https://doi.org/10.3390/molecules26164896. Acesso em: 19 abr. 2024.
APA
Freire, M. C. L. C., Noske, G. D., Bitencourt, N. V., Sanches, P. R. S., Santos-Filho, N. A., Oliveira, V. G. F., et al. (2021). Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors. Molecules, 26( 16), 4896-1-4896-17. doi:10.3390/molecules26164896
NLM
Freire MCLC, Noske GD, Bitencourt NV, Sanches PRS, Santos-Filho NA, Oliveira VGF, Souza EP de, Nogueira VHR, Godoy MO de, Nakamura AM, Fernandes RS, Godoy AS de, Juliano MA, Peres B de M, Barbosa CG, Moraes CB, Freitas Junior LHG de, Cilli EM, Guido RVC, Oliva G. Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors [Internet]. Molecules. 2021 ; 26( 16): 4896-1-4896-17.[citado 2024 abr. 19 ] Available from: https://doi.org/10.3390/molecules26164896
Vancouver
Freire MCLC, Noske GD, Bitencourt NV, Sanches PRS, Santos-Filho NA, Oliveira VGF, Souza EP de, Nogueira VHR, Godoy MO de, Nakamura AM, Fernandes RS, Godoy AS de, Juliano MA, Peres B de M, Barbosa CG, Moraes CB, Freitas Junior LHG de, Cilli EM, Guido RVC, Oliva G. Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors [Internet]. Molecules. 2021 ; 26( 16): 4896-1-4896-17.[citado 2024 abr. 19 ] Available from: https://doi.org/10.3390/molecules26164896
Artigo de periodico
Polymyxin resistance among XDR ST1 carbapenem-resistant Acinetobacter baumannii clone expanding in a teaching hospital (2021)
Carrasco, Letícia Dias de Melo ; Dabul, Andrei Nicoli Gebieluca ; Boralli, Camila Maria dos Santos ; Righetto, Gabriela Marinho; Carvalho, Iago Silva e; Dornelas, Janaína Valerini; Mata, Camila Pacheco Silveira Martins da ; Araújo, César Augusto de ; Leite, Edna Mariléa Meireles ; Huenuman, Nilton Erbet Lincopan ; Camargo, Ilana Lopes Baratella da Cunha
Source: Frontiers in Microbiology. Unidades: ICB, IFSC
Subjects: RESISTÊNCIA MICROBIANA ÀS DROGAS, BACTÉRIAS PATOGÊNICAS, INFECÇÃO HOSPITALAR, MICROBIOLOGIA, POLIMIXINAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARRASCO, Letícia Dias de Melo et al. Polymyxin resistance among XDR ST1 carbapenem-resistant Acinetobacter baumannii clone expanding in a teaching hospital. Frontiers in Microbiology, v. 12, p. 622704-1-622704-11 + supplementary material, 2021Tradução . . Disponível em: https://doi.org/10.3389/fmicb.2021.622704. Acesso em: 19 abr. 2024.
APA
Carrasco, L. D. de M., Dabul, A. N. G., Boralli, C. M. dos S., Righetto, G. M., Carvalho, I. S. e, Dornelas, J. V., et al. (2021). Polymyxin resistance among XDR ST1 carbapenem-resistant Acinetobacter baumannii clone expanding in a teaching hospital. Frontiers in Microbiology, 12, 622704-1-622704-11 + supplementary material. doi:10.3389/fmicb.2021.622704
NLM
Carrasco LD de M, Dabul ANG, Boralli CM dos S, Righetto GM, Carvalho IS e, Dornelas JV, Mata CPSM da, Araújo CA de, Leite EMM, Huenuman NEL, Camargo ILB da C. Polymyxin resistance among XDR ST1 carbapenem-resistant Acinetobacter baumannii clone expanding in a teaching hospital [Internet]. Frontiers in Microbiology. 2021 ; 12 622704-1-622704-11 + supplementary material.[citado 2024 abr. 19 ] Available from: https://doi.org/10.3389/fmicb.2021.622704
Vancouver
Carrasco LD de M, Dabul ANG, Boralli CM dos S, Righetto GM, Carvalho IS e, Dornelas JV, Mata CPSM da, Araújo CA de, Leite EMM, Huenuman NEL, Camargo ILB da C. Polymyxin resistance among XDR ST1 carbapenem-resistant Acinetobacter baumannii clone expanding in a teaching hospital [Internet]. Frontiers in Microbiology. 2021 ; 12 622704-1-622704-11 + supplementary material.[citado 2024 abr. 19 ] Available from: https://doi.org/10.3389/fmicb.2021.622704
Artigo de periodico
2-aminobenzimidazoles for leishmaniasis: from initial hit discovery to in vivo profiling (2021)
Ferreira, Rafael Augusto Alves; Rezende Junior, Celso de ; Martinez, Pablo David Grigol ; Koovits, Paul John ; Soares, Bruna Miranda ; Ferreira, Leonardo Luiz Gomes ; Duarte, Simone Michelan ; Chelucci, Rafael Consolin; Andricopulo, Adriano Defini ; Galuppo, Mariana Kolos ; Uliana, Silvia Reni Bortolin ; Matheeussen, An ; Caljon, Guy ; Maes, Louis ; Campbell, Simon; Kratz, Jadel M. ; Mowbray, Charles E. ; Dias, Luiz Carlos
Source: PLOS Neglected Tropical Diseases. Unidades: IFSC, ICB
Subjects: ANTIPARASITÁRIOS, LEISHMANIA INFANTUM, PLANEJAMENTO DE FÁRMACOS, PARASITOLOGIA, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS, TOXICIDADE EM ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Rafael Augusto Alves et al. 2-aminobenzimidazoles for leishmaniasis: from initial hit discovery to in vivo profiling. PLOS Neglected Tropical Diseases, v. 15, n. 2, p. e0009196-1-e0009196-20, 2021Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0009196. Acesso em: 19 abr. 2024.
APA
Ferreira, R. A. A., Rezende Junior, C. de, Martinez, P. D. G., Koovits, P. J., Soares, B. M., Ferreira, L. L. G., et al. (2021). 2-aminobenzimidazoles for leishmaniasis: from initial hit discovery to in vivo profiling. PLOS Neglected Tropical Diseases, 15( 2), e0009196-1-e0009196-20. doi:10.1371/journal.pntd.0009196
NLM
Ferreira RAA, Rezende Junior C de, Martinez PDG, Koovits PJ, Soares BM, Ferreira LLG, Duarte SM, Chelucci RC, Andricopulo AD, Galuppo MK, Uliana SRB, Matheeussen A, Caljon G, Maes L, Campbell S, Kratz JM, Mowbray CE, Dias LC. 2-aminobenzimidazoles for leishmaniasis: from initial hit discovery to in vivo profiling [Internet]. PLOS Neglected Tropical Diseases. 2021 ; 15( 2): e0009196-1-e0009196-20.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1371/journal.pntd.0009196
Vancouver
Ferreira RAA, Rezende Junior C de, Martinez PDG, Koovits PJ, Soares BM, Ferreira LLG, Duarte SM, Chelucci RC, Andricopulo AD, Galuppo MK, Uliana SRB, Matheeussen A, Caljon G, Maes L, Campbell S, Kratz JM, Mowbray CE, Dias LC. 2-aminobenzimidazoles for leishmaniasis: from initial hit discovery to in vivo profiling [Internet]. PLOS Neglected Tropical Diseases. 2021 ; 15( 2): e0009196-1-e0009196-20.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1371/journal.pntd.0009196
Artigo de periodico
Parasitological profiling shows 4(1H)-quinolone derivatives as new lead candidates for malaria (2021)
Souza, Juliana Oliveira de; Almeida, Suzete M.; Souza, Guilherme Eduardo de ; Zanini, Camila Lima; Silva, Everton Machado da; Paim, Juliana Calit ; Bargieri, Daniel Youssef ; Amporndanai, Kangsa; Antonyuk, Svetlana V. ; Hasnain, S. Samar ; Cruz, Fabio C.; Pereira, Dhelio Batista ; Oliva, Glaucius ; Corrêa, Arlene G. ; Aguiar, Anna Caroline Campos ; Guido, Rafael Victorio Carvalho
Source: European Journal of Medicinal Chemistry Reports. Unidades: ICB, IFSC
Subjects: ANTIMALÁRICOS, ANTIPARASITÁRIOS, MALÁRIA, PLASMODIUM FALCIPARUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Juliana Oliveira de et al. Parasitological profiling shows 4(1H)-quinolone derivatives as new lead candidates for malaria. European Journal of Medicinal Chemistry Reports, v. 3, p. 100012-1-100012-16 + supplementary data, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejmcr.2021.100012. Acesso em: 19 abr. 2024.
APA
Souza, J. O. de, Almeida, S. M., Souza, G. E. de, Zanini, C. L., Silva, E. M. da, Paim, J. C., et al. (2021). Parasitological profiling shows 4(1H)-quinolone derivatives as new lead candidates for malaria. European Journal of Medicinal Chemistry Reports, 3, 100012-1-100012-16 + supplementary data. doi:10.1016/j.ejmcr.2021.100012
NLM
Souza JO de, Almeida SM, Souza GE de, Zanini CL, Silva EM da, Paim JC, Bargieri DY, Amporndanai K, Antonyuk SV, Hasnain SS, Cruz FC, Pereira DB, Oliva G, Corrêa AG, Aguiar ACC, Guido RVC. Parasitological profiling shows 4(1H)-quinolone derivatives as new lead candidates for malaria [Internet]. European Journal of Medicinal Chemistry Reports. 2021 ; 3 100012-1-100012-16 + supplementary data.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.ejmcr.2021.100012
Vancouver
Souza JO de, Almeida SM, Souza GE de, Zanini CL, Silva EM da, Paim JC, Bargieri DY, Amporndanai K, Antonyuk SV, Hasnain SS, Cruz FC, Pereira DB, Oliva G, Corrêa AG, Aguiar ACC, Guido RVC. Parasitological profiling shows 4(1H)-quinolone derivatives as new lead candidates for malaria [Internet]. European Journal of Medicinal Chemistry Reports. 2021 ; 3 100012-1-100012-16 + supplementary data.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.ejmcr.2021.100012

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Grupo de pesquisa

Funding Agencies

Non normalized affiliation